Ricardo Mesa-Tejada
Plus aucun poste en cours
Profil
Ricardo Mesa-Tejada is Vice President of Pathology and Medical for Aureon Laboratories, Inc. and Vice President of Alcan, Inc. He is Associate Clinical Professor of Pathology for the College of Physicians and Surgeons of Columbia University.
Dr. Mesa-Tejada was a Faculty Member of the College of Physicians and Surgeons of Columbia University for 10 years.
He completed training in Anatomic Pathology at the College of Physicians and Surgeons of Columbia University.
Dr. Mesa-Tejada worked at Quest Diagnostics, Inc. He is a Member of the Medical Advisory Board for the Norma F.
Phriem Breast Care Center and the Boards of the Society for Applied Immunohistochemistry, and American Fertility Services.
Dr. Mesa-Tejada was Senior Vice President of Health Sciences for Thieme Consulting, Inc.
Anciens postes connus de Ricardo Mesa-Tejada
| Sociétés | Poste | Fin |
|---|---|---|
Alcan, Inc.
 Alcan, Inc. AluminumNon-Energy Minerals Alcan Inc. produces aluminum products and packaging materials. The company controls 13% of the world's aluminum production capacity. It mines bauxite (aluminum ore) and makes and recycles aluminum sheet, foil, wire and cable, and extrusions (doors, windows, auto parts). It also generates hydroelectric power and makes aluminum-related specialty chemicals and packaging products. It is headquartered in Montreal, Canada. | Corporate Officer/Principal | 28/01/2008 |
| QUEST DIAGNOSTICS INCORPORATED | Corporate Officer/Principal | - |
Aureon Biosciences, Inc.
 Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QUEST DIAGNOSTICS INCORPORATED | Health Services |
| Entreprise privées | 2 |
|---|---|
Alcan, Inc.
Alcan, Inc. AluminumNon-Energy Minerals Alcan Inc. produces aluminum products and packaging materials. The company controls 13% of the world's aluminum production capacity. It mines bauxite (aluminum ore) and makes and recycles aluminum sheet, foil, wire and cable, and extrusions (doors, windows, auto parts). It also generates hydroelectric power and makes aluminum-related specialty chemicals and packaging products. It is headquartered in Montreal, Canada. | Non-Energy Minerals |
Aureon Biosciences, Inc.
Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Health Technology |
